1 US FDA 510(k) clinical summary (k181518).
2 Paithankar et al. 2015. Acne Treatment Based on Selective Photothermolysis of Sebaceous Follicles with Topically Delivered Light-Absorbing Gold Microparticles. Journal of Investigational Dermatology, July 2015. 135 (7): pgs. 1727-1734.
3 The US clinical study ended at 12 weeks and demonstrated non-inferiority to laser alone with Sebacia’s last treatment at 2 weeks and laser alone last treatment at 10 weeks, Sebacia’s treatment required significantly fewer laser treatment sessions and significantly lower laser fluence compared to laser alone.
In a non-randomized registry study in Europe, the average improvement in acne lesions at 24 months was 92% (77% free of acne medications, 9% used topicals and 14% used systemics at 24 months).